{"entity":{"type":"insider","cik":"0001673852","url":"/insider/0001673852","json_url":"/insider/0001673852.json","name":"Novartis Institutes for BioMedical Research, Inc.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":3,"n_filings":3,"first":"2016-05-11","last":"2018-04-23","span_basis":"filed_date"},"name_variants":[{"name":"Novartis Institutes for BioMedical Research, Inc.","source":"filing","n_filings":3,"first_seen":"2016-05-11","last_seen":"2018-04-23"}],"transactions":[{"id":6517175,"accession":"0001104659-18-025864","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-18-025864","line_url":"/filing/0001104659-18-025864#line-3","is_derivative":false,"issuer_cik":"0001114448","issuer_name":"Surface Oncology, Inc.","issuer_ticker":"SURF","issuer_name_source":null,"issuer_url":"/issuer/0001114448","owner_cik":null,"owner_name":"Novartis Institutes for BioMedical Research, Inc.; NOVARTIS AG","owner_display_name":"Novartis Institutes for BioMedical Research, Inc.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":766666.0,"shares_display":"766,666","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":11499990.0,"total_display":"11,499,990.00","total_whole":"11,499,990","shares_owned_after":3948482.0,"shares_owned_after_display":"3,948,482","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-23","filed_date":"2018-04-23","scope":"insider"},{"id":5167737,"accession":"0001104659-17-073312","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-17-073312","line_url":"/filing/0001104659-17-073312#line-1","is_derivative":false,"issuer_cik":"0001114448","issuer_name":"Intellia Therapeutics, Inc.","issuer_ticker":"NTLA","issuer_name_source":null,"issuer_url":"/issuer/0001114448","owner_cik":null,"owner_name":"NOVARTIS AG; Novartis Institutes for BioMedical Research, Inc.","owner_display_name":"NOVARTIS AG","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1523000.0,"shares_display":"1,523,000","price_per_share":18.3,"price_display":"18.30","price_state":"stated","total_value":27870900.0,"total_display":"27,870,900.00","total_whole":"27,870,900","shares_owned_after":4129903.0,"shares_owned_after_display":"4,129,903","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-12","filed_date":"2017-12-14","scope":"insider"},{"id":2924059,"accession":"0001209191-16-119312","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-16-119312","line_url":"/filing/0001209191-16-119312#line-4","is_derivative":false,"issuer_cik":"0001114448","issuer_name":"Intellia Therapeutics, Inc.","issuer_ticker":"NTLA","issuer_name_source":null,"issuer_url":"/issuer/0001114448","owner_cik":null,"owner_name":"NOVARTIS AG; Novartis Institutes for BioMedical Research, Inc.","owner_display_name":"NOVARTIS AG","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":277777.0,"shares_display":"277,777","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":4999986.0,"total_display":"4,999,986.00","total_whole":"4,999,986","shares_owned_after":5573658.0,"shares_owned_after_display":"5,573,658","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-11","filed_date":"2016-05-11","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001718108","name":"Surface Oncology, Inc.","url":"/issuer/0001718108","role":"Ten percent owner","n_filings":1,"first_seen":"2018-04-23","last_seen":"2018-04-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001652130","name":"Intellia Therapeutics, Inc.","url":"/issuer/0001652130","role":"Ten percent owner","n_filings":2,"first_seen":"2016-05-11","last_seen":"2017-12-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001673852","retrieved_at":"2026-08-23T10:52:09+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}